Purpose: This study aimed to report a case of microplastics (MPs) detection in a pterygium patient's tissue.

Case Report: A pterygium specimen was obtained from the right eye of a 43-year-old woman by surgical removal of a recurred pterygium. The number, morphology, and material type of the MPs in pterygium were identified using Raman microscopy and scanning electron microscopy. Ten MPs were detected in the pterygium, which corresponded to polyethylene (PE) (n = 7), polystyrene (PS) (n = 2), and polypropylene (PP) (n = 1). The size of MPs ranged from 5-9 µm (n = 5, PE or PS), 10-19 µm (n = 4, PE), and 50-99 µm (n = 1, PP). All MPs were transparent and irregular fragments.

Conclusions: This study demonstrated the detection of MPs in the pterygium tissue. Our findings suggest that environmental hazards, such as MP, may be commonly exposed to the ocular surface.

Download full-text PDF

Source
http://dx.doi.org/10.1177/11206721241310467DOI Listing

Publication Analysis

Top Keywords

pterygium tissue
8
environmental hazards
8
mps pterygium
8
pterygium
7
mps
6
detection microplastics
4
microplastics pterygium
4
tissue implications
4
implications environmental
4
hazards purpose
4

Similar Publications

Purpose: This study aimed to report a case of microplastics (MPs) detection in a pterygium patient's tissue.

Case Report: A pterygium specimen was obtained from the right eye of a 43-year-old woman by surgical removal of a recurred pterygium. The number, morphology, and material type of the MPs in pterygium were identified using Raman microscopy and scanning electron microscopy.

View Article and Find Full Text PDF

We describe a novel technique for recurrent pterygium and assess the advantage of properties of extended tenonectomy, amniotic membrane transplantation, and limbal epithelial transplantation in terms of recurrence rate, postoperative symptoms, postoperative orthoptics, and other complications. A total of nine eyes with recurrent pterygium underwent PERMISLET, i.e.

View Article and Find Full Text PDF

Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor.

Sci Rep

December 2024

Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, RM305v, 1160 W. Michigan St., Indianapolis, IN, 46202, USA.

Pterygium is an ocular disease in which the conjunctival tissue invades the cornea. When the pterygium tissue reaches the pupillary region, the visual function of the patient is affected. Currently, surgical removal is the only effective treatment.

View Article and Find Full Text PDF

Background: Pterygium is a complex ocular surface disease characterized by the abnormal proliferation and growth of conjunctival and fibrovascular tissues at the corneal-scleral margin. Understanding the underlying molecular mechanisms of pterygium is crucial for developing effective diagnostic and therapeutic strategies.

Methods: To elucidate the molecular mechanisms of pterygium, we conducted a differential gene expression analysis between pterygium and normal conjunctival tissues using high-throughput RNA sequencing.

View Article and Find Full Text PDF

Purpose: To characterize corneal and conjunctival abnormalities (CCAs) and their impact on visual acuity in a cohort of survivors from the Western African Ebola virus disease (EVD) outbreak.

Design: A post hoc analysis of 121 patients, who had previously undergone screening for the Ebola Virus Persistence in Ocular Tissues and Fluids study, was performed.

Methods: Patients underwent a comprehensive ophthalmic exam at the Lowell and Ruth Gess Eye Hospital in Freetown, Sierra Leone.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!